NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 237 filers reported holding NEKTAR THERAPEUTICS in Q1 2021. The put-call ratio across all filers is 0.96 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $34,109 | -68.5% | 48,709 | +1.8% | 0.00% | -75.0% |
| Q4 2022 | $108,166 | -84.1% | 47,861 | -77.7% | 0.00% | -81.8% |
| Q3 2022 | $679,000 | -22.4% | 214,322 | -7.0% | 0.02% | -15.4% |
| Q2 2022 | $875,000 | +67.9% | 230,411 | +138.4% | 0.03% | +85.7% |
| Q1 2022 | $521,000 | -54.2% | 96,652 | +14.9% | 0.01% | -53.3% |
| Q4 2021 | $1,137,000 | -25.3% | 84,152 | -0.7% | 0.03% | -34.8% |
| Q3 2021 | $1,522,000 | -11.5% | 84,777 | -15.4% | 0.05% | -11.5% |
| Q2 2021 | $1,719,000 | -14.7% | 100,203 | -0.5% | 0.05% | -23.5% |
| Q1 2021 | $2,015,000 | +18.5% | 100,706 | +0.6% | 0.07% | -1.4% |
| Q4 2020 | $1,701,000 | +62.0% | 100,074 | +58.2% | 0.07% | +32.7% |
| Q3 2020 | $1,050,000 | -37.2% | 63,261 | -12.4% | 0.05% | -40.9% |
| Q2 2020 | $1,673,000 | +32.8% | 72,240 | +2.3% | 0.09% | +7.3% |
| Q1 2020 | $1,260,000 | -53.2% | 70,622 | -43.4% | 0.08% | -50.9% |
| Q4 2019 | $2,695,000 | +256.5% | 124,853 | +200.7% | 0.17% | +153.0% |
| Q3 2019 | $756,000 | -62.6% | 41,519 | -26.9% | 0.07% | -59.5% |
| Q2 2019 | $2,020,000 | -45.6% | 56,778 | -48.6% | 0.16% | -18.5% |
| Q1 2019 | $3,714,000 | +102.5% | 110,551 | +98.1% | 0.20% | +94.2% |
| Q4 2018 | $1,834,000 | -46.5% | 55,811 | -0.7% | 0.10% | -23.1% |
| Q3 2018 | $3,428,000 | +32.5% | 56,228 | +6.1% | 0.13% | +31.4% |
| Q2 2018 | $2,588,000 | -18.8% | 52,994 | +49.9% | 0.10% | -21.5% |
| Q1 2018 | $3,188,000 | +104.2% | 35,354 | +65.7% | 0.13% | +85.7% |
| Q4 2017 | $1,561,000 | – | 21,339 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 3,500,000 | $60,060,000 | 2.02% |
| ACT CAPITAL MANAGEMENT, LLC | 161,500 | $2,772,000 | 1.42% |
| Rhenman & Partners Asset Management AB | 950,000 | $16,302,000 | 1.11% |
| MAVERICK CAPITAL LTD | 5,761,073 | $98,860,000 | 0.93% |
| Birchview Capital, LP | 72,000 | $1,236,000 | 0.74% |
| Bellevue Group AG | 4,101,404 | $70,380,000 | 0.69% |
| CM Management, LLC | 50,000 | $858,000 | 0.62% |
| Duquesne Family Office | 1,000,000 | $17,160,000 | 0.42% |
| OSTERWEIS CAPITAL MANAGEMENT INC | 373,368 | $6,407,000 | 0.33% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 67,000 | $1,149,000 | 0.30% |